Search results for " availability"

showing 10 items of 287 documents

Regulation of free choline in rat brain: dietary and pharmacological manipulations.

1998

The present study analyses, comparatively, the kinetics of free choline in the brain of rats during dietary and pharmacological manipulations. Low-choline diet halved the choline plasma level but did not cause significant changes of CSF choline. High-choline diet, hypoxia and treatment with nicotinamide increased brain choline availability through a central site of action and increased the CSF choline concentration. CSF choline concentrations were more effectively elevated by nicotinamide treatment (20-25 microM) than by acute choline administration (13-15 microM). Increases of CSF choline, due to brain choline mobilization, were consistently associated with a net release of choline from th…

MaleNiacinamidemedicine.medical_specialtyCerebral arteriesCentral nervous systemBiological AvailabilityBiologyCholineCellular and Molecular Neurosciencechemistry.chemical_compoundInternal medicinemedicineCholineAnimalsRats WistarHypoxiaNicotinamideOsmolar ConcentrationBrainCell BiologyVenous bloodHypoxia (medical)Cerebral ArteriesCerebral VeinsDietRatsEndocrinologymedicine.anatomical_structurechemistrymedicine.symptomAcetylcholineHomeostasismedicine.drugNeurochemistry international
researchProduct

Ocular tolerability and in vivo bioavailability of poly(ethylene glycol) (PEG)-coated polyethyl-2-cyanoacrylate nanosphere-encapsulated acyclovir.

2001

Acyclovir-loaded polyethyl-2-cyanoacrylate (PECA) nanospheres were prepared by an emulsion polymerization process in the micellar phase and characterized. The influence of the presence of nonionic surfactant as well as other substances [i.e., 2-hydroxypropyl-beta-cyclodextrin (HP-beta-CyD) and poly(ethylene glycol) (PEG)], on formulation parameters and loading capacity was investigated. In particular, the presence of PEG resulted in an increase of mean size and size distribution. To obtain PEG-coated PECA nanospheres with a mean size of200 nm, Pluronic F68 at concentrations1.5% (w/v) should be used during preparation. The presence of PEG also resulted in a change in zeta potential, from -25…

MalePharmaceutical ScienceEmulsion polymerizationAcyclovirBiological AvailabilityEyeAntiviral AgentsDosage formPolyethylene Glycolschemistry.chemical_compoundPEG ratioZeta potentialMucoadhesionOrganic chemistryAnimalsCyanoacrylatesParticle SizeDrug Carrierstechnology industry and agricultureMicrospheresBioavailabilitychemistryRabbitsDrug carrierEthylene glycolNuclear chemistryJournal of pharmaceutical sciences
researchProduct

The effects of three absorption-modifying critical excipients on the in vivo intestinal absorption of six model compounds in rats and dogs.

2018

Pharmaceutical excipients that may affect gastrointestinal (GI) drug absorption are called critical pharmaceutical excipients, or absorption-modifying excipients (AMEs) if they act by altering the integrity of the intestinal epithelial cell membrane. Some of these excipients increase intestinal permeability, and subsequently the absorption and bioavailability of the drug. This could have implications for both the assessment of bioequivalence and the efficacy of the absorption-enhancing drug delivery system. The absorption-enhancing effects of AMEs with different mechanisms (chitosan, sodium caprate, sodium dodecyl sulfate (SDS)) have previously been evaluated in the rat single-pass intestin…

MalePharmaceutical ScienceExcipientBiological Availability02 engineering and technologyBioequivalencePharmacology030226 pharmacology & pharmacyIntestinal absorptionPermeabilityExcipients03 medical and health sciences0302 clinical medicineDogsIn vivomedicineAnimalsPharmaceutical sciencesIntestinal MucosaChitosanIntestinal permeabilityChemistrySodium Dodecyl Sulfate021001 nanoscience & nanotechnologymedicine.diseaseBioavailabilityRatsIntestinesIntestinal AbsorptionPharmaceutical PreparationsDrug delivery0210 nano-technologyDecanoic Acidsmedicine.drugInternational journal of pharmaceutics
researchProduct

INULIN BASED HYDROGEL FOR ORAL DELIVERY OF FLUTAMIDE: PREPARATION, CHARACTERIZATION AND IN VIVO RELEASE STUDIES

2012

The ability of a hydrogel obtained by crosslinking INUDV and PEGBa to facilitate sustained release of flutamide is examined. The hydrogel is prepared in pH = 7.4 PBS and no toxic solvents or catalysts are used. It is recovered in microparticulate form and its size distribution is determined. Mucoadhesive properties are evaluated in vitro by reproducing gastrointestinal conditions. Flutamide is loaded into the hydrogel using a post-fabrication encapsulation procedure that allows a drug loading comparable to that of market tablets. Drug-loaded microparticles are orally administered to cross-bred dogs and the in vivo study demonstrates their ability to prolong the half-life of the principal ac…

MalePolymers and PlasticsInulinAdministration OralBiological AvailabilityBioengineeringPharmacologyFlutamideBiomaterialschemistry.chemical_compoundDogsDrug Delivery SystemsIn vivoMaterials ChemistryDistribution (pharmacology)AnimalsHypoglycemic AgentsInsulinActive metabolitetechnology industry and agricultureAndrogen AntagonistsHydrogelsIn vitroFlutamideBioavailabilitychemistrySelf-healing hydrogelsBiotechnologyHalf-Life
researchProduct

Extended release and enhanced bioavailability of moxifloxacin conjugated with hydrophilic cellulose ethers.

2015

Macromolecular prodrugs (MPDs) of moxifloxacin were fabricated based on hydroxypropylcellulose (HPC) and hydroxyethylcellulose (HEC). UV/Vis spectrophotometry was employed to determine covalently loaded drug content (DC) of each conjugate. The degree of substitution (DS) of moxifloxacin attained ranged from 0.27 to 0.38 (HPC) and 0.19 to 0.26 (HEC) per anhydroglucose unit (AGU), respectively. Transmission electron microscopic analyses showed that HPC-moxifloxacin conjugates self-assembled into nanowires of ∼ 30 nm diameters while HEC-moxifloxacin conjugates self-assembled into nanoparticles of 150-350 nm. In vitro drug release studies revealed that 15 and 49% moxifloxacin release occurred f…

MalePolymers and PlasticsKineticsMoxifloxacinBiological Availability02 engineering and technology010402 general chemistry01 natural scienceschemistry.chemical_compoundPharmacokineticsMoxifloxacinSpectrophotometryMaterials ChemistrymedicineAnimalsheterocyclic compoundsProdrugsCelluloseCelluloseChromatographymedicine.diagnostic_testOrganic Chemistrybiochemical phenomena metabolism and nutritionProdrugbacterial infections and mycoses021001 nanoscience & nanotechnology0104 chemical sciencesBioavailabilityDrug LiberationKineticschemistryDelayed-Action PreparationsRabbits0210 nano-technologyHydrophobic and Hydrophilic Interactionsmedicine.drugConjugateFluoroquinolonesCarbohydrate polymers
researchProduct

Polyhydroxyethylaspartamide-based micelles for ocular drug delivery

2009

In this paper three copolymers of polyhydroxyethylaspartamide (PHEA), bearing in the side chains polyethylene glycol (PEG) and/or hexadecylamine (C(16)) (PHEA-PEG, PHEA-PEG-C(16) and PHEA-C(16) respectively) have been studied as potential colloidal drug carriers for ocular drug delivery. The physical characterization of all three PHEA derivatives, using the Langmuir trough (LT) and micellar affinity capillary electrophoresis (MACE) techniques allowed to assume that whereas alone PHEA backbone is an inert polymer with respect to the interactions with lipid membranes and drug complexation, when PHEA chains are grafted with long alkyl chains like C(16) or in combination C(16) chains and hydrop…

MalePolymersAdministration TopicalBiological AvailabilityPharmaceutical SciencePolyethylene glycolMicelleDexamethasonePermeabilityPolyethylene Glycolschemistry.chemical_compoundocular drug delivery systemIn vivoPEG ratioAnimalsColloidsNetilmicinAminesLipid bilayerMicellesDrug CarriersChromatographyChemistryEpithelium Cornealtechnology industry and agricultureHydrocarbonsBioavailabilityDrug deliverypolymeric micelles amphiphilic copolymersRabbitsPeptidesDrug carrierConjunctiva
researchProduct

Influence of polymer molecular weight on in vitro dissolution behavior and in vivo performance of celecoxib:PVP amorphous solid dispersions

2016

In this study, the influence of the molecular weight of polyvinylpyrrolidone (PVP) on the non-sink in vitro dissolution and in vivo performance of celecoxib (CCX):PVP amorphous solid dispersions were investigated. The dissolution rate of CCX from the amorphous solid dispersions increased with decreasing PVP molecular weight and crystallization inhibition was increased with increasing molecular weight of PVP, but reached a maximum for PVP K30. This suggested that the crystallization inhibition was not proportional with molecular weight of the polymer, but rather there was an optimal molecular weight where the crystallization inhibition was strongest. Consistent with the findings from the non…

MalePolymersChemistry PharmaceuticalBiological AvailabilityPharmaceutical Science02 engineering and technology030226 pharmacology & pharmacylaw.inventionRats Sprague-Dawley03 medical and health sciences0302 clinical medicineIn vivolawmedicineAnimalsOrganic chemistryCrystallizationDissolutionchemistry.chemical_classificationPolyvinylpyrrolidoneChemistrytechnology industry and agriculturePovidoneGeneral MedicinePolymer021001 nanoscience & nanotechnologyRatsAmorphous solidBioavailabilityMolecular WeightSolubilityChemical engineeringCelecoxibCrystallization0210 nano-technologyDispersion (chemistry)Biotechnologymedicine.drugEuropean Journal of Pharmaceutics and Biopharmaceutics
researchProduct

Bioavailability and pharmacokinetic model for ritonavir in the rat.

2007

The aim of this study is to investigate in vivo the oral bioavailability of ritonavir and to evaluate the pharmacokinetic model that best describes the plasma concentration behavior after oral and intravenous administration. Male Wistar rats were intravenously administered at 3 mg dose of pure ritonavir and oral administered at 4.6 +/- 2.5 mg of diluted Norvir. Blood samples were taken by means of the jugular vein for a 24 h period of time. An analytical high-performance liquid chromatography (HPLC) technique was developed in order to quantify ritonavir plasma concentrations. A nonlinear modeling approach was used to estimate the pharmacokinetic parameters of interest. Results showed that a…

MaleRitonavirbiologyChemistryPharmaceutical ScienceBiological AvailabilityAbsorption (skin)PharmacologyHigh-performance liquid chromatographyModels BiologicalBioavailabilityAbsorptionRatsPharmacokineticsIn vivoEnzyme inhibitormedicinebiology.proteinAnimalsRitonavirProtease inhibitor (pharmacology)Rats Wistarmedicine.drugJournal of pharmaceutical sciences
researchProduct

Relationship between the Clinical Frailty Scale and short-term mortality in patients ≥ 80 years old acutely admitted to the ICU: a prospective cohort…

2021

Abstract Background The Clinical Frailty Scale (CFS) is frequently used to measure frailty in critically ill adults. There is wide variation in the approach to analysing the relationship between the CFS score and mortality after admission to the ICU. This study aimed to evaluate the influence of modelling approach on the association between the CFS score and short-term mortality and quantify the prognostic value of frailty in this context. Methods We analysed data from two multicentre prospective cohort studies which enrolled intensive care unit patients ≥ 80 years old in 26 countries. The primary outcome was mortality within 30-days from admission to the ICU. Logistic regression models for…

MaleShort term mortalityCritical Care and Intensive Care MedicineCohort Studies0302 clinical medicinekwetsbaarheidMedicine and Health Sciences80 and overMedicine610 Medicine & healthProspective cohort studyCorrelation of Data11 Medical and Health SciencesAged 80 and overOUTCOMESIntensive care unitsFrailtyVIP1Aged&nbspMedical emergencies. Critical care. Intensive care. First aidScale (social sciences)Femaleprospectief onderzoekLife Sciences & BiomedicineCRITICALLY-ILL PATIENTS 80 and overStudy groupsmedicine.medical_specialtyAnestesi och intensivvård80 jaar en ouder610 Medicine & healthINTENSIVE-CAREBED AVAILABILITYNO03 medical and health sciencesCritical Care MedicineIntensive caresterfteGeneral & Internal MedicineHumansIntensive care units; Aged; 80 and over; Frailty; Prospective studies; MortalityIn patientddc:610Aged 80 and over; Frailty; Intensive care units; Mortality; Prospective studies; Aged 80 and over; Cohort Studies; Correlation of Data; Female; Frailty; Humans; Intensive Care Units; Logistic Models; Male; Mortality; Prospective StudiesMortalityAgedScience & TechnologyAnesthesiology and Intensive Carebusiness.industryRC86-88.9Research030208 emergency & critical care medicineADULTSAged 80 and over; Frailty; Intensive care units; Mortality; Prospective studies;Emergency & Critical Care MedicineLogistic Models030228 respiratory systemintensivecareafdelingenAged 80 and overCritical illnessEmergency medicineVIP2 study group&nbspCRITICAL ILLNESSbusinessProspective studies
researchProduct

Effects of the flavonol quercetin on the bioavailability of simvastatin in pigs

2009

The influence of the dietary flavonol quercetin on the pharmacokinetics of the HMG-CoA reductase inhibitor simvastatin was investigated in pigs. Simvastatin (0.25mg/kg body weight) was orally administered to six pigs either without or with quercetin (10mg/kg). In addition, simvastatin was administered to three pigs that had received a diet supplemented with the flavonol over a period of 1 week. Daily quercetin intake was 10mg/kg in these animals. Co-ingestion of quercetin with the statin did not alter area under the concentration time curve (AUC(0-->infinity)), time to achieve maximum plasma concentration (t(max)) or half-life (t(1/2)) of simvastatin. However, there was a trend towards a re…

MaleSimvastatinStatinFlavonolsSwinemedicine.drug_classBiological AvailabilityPharmaceutical SciencePharmacologyFood-Drug Interactionschemistry.chemical_compoundPharmacokineticsBlood plasmapolycyclic compoundsmedicineAnimalsIngestionheterocyclic compoundscardiovascular diseasesCross-Over StudiesbiologyChemistrynutritional and metabolic diseasesBioavailabilitySimvastatinHMG-CoA reductasebiology.proteinQuercetinlipids (amino acids peptides and proteins)Quercetinmedicine.drugEuropean Journal of Pharmaceutical Sciences
researchProduct